Burke Neurological Institute
Menu
Skip to main content
Our Team
Contact Us
Donate
Clinical Trials
Search form
Search
About Us
Conditions
Faculty / Research Labs & Core Facilities
News & Impact
Future Talent
Events
About Us
+
About the Institute
Our Mission & Vision
Our History
Our Leadership
Our Boards
Our Team
Affiliations & Partners
Funding Sources
Brand Toolkit
Research Compliance
Campus Guide
Covid-19 Guidelines for Vendors
Contact Us
Conditions
+
Neurological Conditions
Stroke
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Neurodegenerative Diseases
Retinal Degenerative Diseases
Neurological Recovery
Motor Recovery
Pain & Sensory Recovery
Cognitive Recovery
Vision Recovery
Find a Clinical Trial
Inquire About Trials
Research Registry
Center for Pain & Sensory
Center for Vision Repair
Resilience Program
Campus Guide
Faculty / Research Labs & Core Facilities
+
Research Labs & Cores
Cho Lab
Friel Lab
Gibson Lab
Hollis Lab
Marshel Lab
Prusky Lab
Ratan Lab
Sahni Lab
Travis Lab
Willis Lab
Yoshida Lab
Imaging Core
SCI Core
Research Methods
News & Impact
+
Recent News & Impact
News
Publications
Grants
Presentations
Future Talent
+
Programs & Opportunities
Open Job Positions
Summer Science
Intro to Neuroscience
NeuroAcademy
Postdoctoral Fellow
Graduate Medical Fellow
Undergraduate
High School
Events
+
Upcoming Events
Archived Events
Webinar Series
You are here
Home
>
Drug Discovery
Drug Discovery
Impact
Gibson Lab
PUBLICATION:
Journal Article
Freeman GB, Sherman KA, Gibson GE.
Locomotor activity as a predictor of times and dosages for studies of nicotine's neurochemical actions.
Pharmacol Biochem Behav. 1987 Feb;26(2):305-12.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Freeman GB, Gibson GE.
Effect of decreased oxygen on in vitro release of endogenous 3,4-dihydroxyphenylethylamine from mouse striatum.
J Neurochem. 1986 Dec;47(6):1924-31.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Freeman GB, Nielsen P, Gibson GE.
Behavioral and neurochemical correlates of morphine and hypoxia interactions.
Pharmacol Biochem Behav. 1986 Jun;24(6):1687-93.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Nicholls DG, Gibson GE.
Subsynaptosomal calcium distribution during hypoxia and 3,4-diaminopyridine treatment.
J Neurochem. 1985 Dec;45(6):1779-90.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Nicholls DG, Gibson GE.
Subsynaptosomal distribution of calcium during aging and 3,4-diaminopyridine treatment.
Neurobiol Aging. 1985 Winter;6(4):297-304.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Hirsch JA, Gibson GE.
Thiamin antagonists and the release of acetylcholine and norepinephrine from brain slices.
Biochem Pharmacol. 1984 Jul 15;33(14):2325-7. No abstract available.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Gibson GE.
Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment.
J Neurochem. 1984 Jan;42(1):248-53.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Gibson GE.
Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake.
J Biol Chem. 1983 Oct 10;258(19):11482-6.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Gibson GE, Pelmas CJ, Peterson C.
Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
Pharmacol Biochem Behav. 1983 Jun;18(6):909-16.
Abstract on PubMed
Gibson Lab
PUBLICATION:
Journal Article
Peterson C, Gibson GE.
Amelioration of age-related neurochemical and behavioral deficits by 3,4-diaminopyridine.
Neurobiol Aging. 1983 Spring;4(1):25-30.
Abstract on PubMed
« first
‹ previous
…
8
9
10
11
12
13
14
(current)
15
16
next ›
last »
Causes
Neurodegenerative Diseases
,
Stroke
,
Spinal Cord Injury
,
Retinal Degenerative Diseases
,
Cognitive Recovery
,
Vision Recovery